Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Thrombosis, bleeding, and progression in JAK2 V617F clonal hematopoiesis

Rathnam Venkat, Robert Redd, Gabriela Hobbs, Chi-Joan How

Blood (2025) 146 (Supplement 1): 3168.

https://doi.org/10.1182/blood-2025-3168

Published: 2025

Journal Articles

Real-world treatment patterns and clinical outcomes in patients with essential thrombocythemia treated with cytoreductive therapy: A retrospective analysis of electronic health records data

Evan Chen, Xiaoqin Yang, Mavis Obeng-Kusi, Uzor Ogbu, Rose Chang, Priyanka Bobbili, Louise Clear, Zhuo Chen, Yidan Ma, Yichuan Grace Hsieh, Christopher Herrick, Mei Sheng Duh, Shawn Murphy, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 2837.

https://doi.org/10.1182/blood-2025-2837

Published: 2025

Journal Articles

The association of a novel psychosocial and mobility assessment with outcomes of veterans with acute myeloid leukemia (AML)

Michelle Lee, Nhan Do, Mary Brophy, Amir Fathi, Areej El-Jawahri, Gabriela Hobbs, Elyse Park, Nathanael Fillmore, Clark DuMontier, Jennifer La

Blood (2025) 146 (Supplement 1): 2836.

https://doi.org/10.1182/blood-2025-2836

Published: 2025

Journal Articles

A retrospective study to assess real-world treatment patterns and outcomes in luspatercept-treated patients with myelofibrosis-associated anemia who required red blood cell transfusion in the United States

Gabriela Hobbs, Ying Liu, Fabian Sanabria, Shalon Jones, Yeran Li

Blood (2025) 146 (Supplement 1): 2825.

https://doi.org/10.1182/blood-2025-2825

Published: 2025

Journal Articles

Peripheral blood plasma proteomics reveals dysregulated cholesterol transport and complement pathways in myeloproliferative neoplasms

Max Petersen, Anna Chorzalska, John Reagan, Nagib Ahsan, James He, Michael Clarke, Omonike Oyelola, Stephen Donnelly, Rabin Niroula, Thomas Ollila, Orly Leiva, Gabriela Hobbs, Patrycja Dubielecka

Blood (2025) 146 (Supplement 1): 3245.

https://doi.org/10.1182/blood-2025-3245

Published: 2025

Journal Articles

Decreased serum total cholesterol is associated with worse outcomes among patients with myeloproliferative neoplasms

Orly Leiva, Steven Soo, Olivia Liu, Victor You, Andrew Palmer, Justin Kahla, Yasmeen Murtaza, Olatoyosi Odenike, Anand Patel, Jeanne DeCara, Michelle Lee, Chi-Joan How, Max Petersen, Patrycja Dubielecka, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 2020.

https://doi.org/10.1182/blood-2025-2020

Published: 2025

Journal Articles

Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients

Blood (2025) 146 (Supplement 1): 1026.

https://doi.org/10.1182/blood-2025-1026

Published: 2025

Journal Articles

Clinical features and outcomes of myelofibrosis patients with MPL mutations

Yu-Han Chen, Shruti Gajjar, Victor You, Rami Komrokji, Valentina Nardi, Harrison Tsai, Andrew Kuykendall, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 5601.

https://doi.org/10.1182/blood-2025-5601

Published: 2025

Journal Articles

Clinical features and outcomes of myeloproliferative neoplasm patients with MPL mutations and concurrent JAK2/calr mutations

Yu-Han Chen, Shruti Gajjar, Victor You, Rami Komrokji, Valentina Nardi, Harrison Tsai, Zhuoer Xie, Andrew Kuykendall, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 7354.

https://doi.org/10.1182/blood-2025-7354

Published: 2025

Journal Articles

Pulmonary hypertension on right heart catheterization is associated with worse progression-free survival in patients with myeloproliferative neoplasms

Orly Leiva, Olivia Liu, Victor You, Steven Soo, Justin Kahla, Yasmeen Murtaza, Andrew Palmer, Anand Patel, Olatoyosi Odenike, Michelle Lee, Chi-Joan How, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 5583.

https://doi.org/10.1182/blood-2025-5583

Published: 2025

Journal Articles

Impact of statin use on cardiovascular and hematologic outcomes among patients with myeloproliferative neoplasms

Orly Leiva, Steven Soo, Olivia Liu, Victor You, Andrew Palmer, Justin Kahla, Yasmeen Murtaza, Olatoyosi Odenike, Anand Patel, Jeanne DeCara, Max Petersen, Patrycja Dubielecka, Michelle Lee, Chi-Joan How, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 5571.

https://doi.org/10.1182/blood-2025-5571

Published: 2025

Journal Articles

Retrospective real-world analysis of ropeginterferon ALFA-2B use in patients with polycythemia vera and essential thrombocythemia: Practice patterns, tolerance, and outcomes

Katherine Feder, Jessica Freydman, Yue Ren, Shruti Gajjar, Victor You, David Sirignano, Svitlana Tyekucheva, Andrew Brunner, Jean M. Connors, Daniel Deangelo, Amir Fathi, Jacqueline Garcia, Chi-Joan How, Marlise Luskin, Richard Stone, Virginia Volpe, Michelle Lee, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 7338.

https://doi.org/10.1182/blood-2025-7338

Published: 2025

Journal Articles

Evaluating real-world diagnostic and treatment patterns, risk of thromboembolic events, and mortality for polycythemia vera across an integrated academic-community cancer network

Jessica Nino De Rivera, Orly Leiva, Vasileios Efthymiou, Odette Iskandar, Jessica Freydman, Gabriela Hobbs, Michelle Lee

Blood (2025) 146 (Supplement 1): 6390.

https://doi.org/10.1182/blood-2025-6390

Published: 2025

Journal Articles

Examining diet quality and patient-reported outcomes in myeloproliferative neoplasms: Results from a cross-sectional observational study

Chi-Joan How, Cami Christopher, Brunhilda Nkengfack, Richard Newcomb, Bridget Coffey, Victor You, Gabriela Hobbs, Hermioni Amonoo, Areej El-Jawahri, Christina Dieli-Conwright

Blood (2025) 146 (Supplement 1): 6387.

https://doi.org/10.1182/blood-2025-6387

Published: 2025

Journal Articles

A phase I study of the combination of ruxolitinib and the ERK1/2 inhibitor ulixertinib in previously treated myelofibrosis patients.

Chi-Joan How, Gabriela Hobbs, Aaron Gerds, Andriy Derkach, Emily Burton, Aurora Duran, Katherine Kan, Michael Mauro, Brian Chernak, Tamanna Haque, Raajit Rampal

Blood (2025) 146 (Supplement 1): 5606.

https://doi.org/10.1182/blood-2025-5606

Published: 2025

Journal Articles

Not so exclusive: Co-mutations in JAK2, MPL and CALR define distinct hematologic and clonal signatures

Ekrem Turk, Fernando Bustamante, Fatima Tuz Zahra, Yu-Han Chen, Rory Shallis, Onyee Chan, Samuel Reynolds, Alison Walker, Ling Zhang, Seongseok Yun, Jeffrey Lancet, David Sallman, Rami Komrokji, Jinming Song, Eric Padron, Gabriela Hobbs, Andrew Kuykendall, Zhuoer Xie

Blood (2025) 146 (Supplement 1): 3815.

https://doi.org/10.1182/blood-2025-3815

Published: 2025

Journal Articles

Ruxolitinib and cardiovascular outcomes among patients with myelofibrosis

Orly Leiva, Steven Soo, Olivia Liu, Victor You, Andrew Palmer, Justin Kahla, Yasmeen Murtaza, Olatoyosi Odenike, Anand Patel, Jeanne DeCara, Michelle Lee, Chi-Joan How, Gabriela Hobbs

Blood (2025) 146 (Supplement 1): 3796.

https://doi.org/10.1182/blood-2025-3796

Published: 2025

Journal Articles

Results from paradigm - a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemotherapy for newly diagnosed fit adults with acute myeloid leukemia

Blood (2025) 146 (Supplement 1): 6.

https://doi.org/10.1182/blood-2025-6

Published: 2025

Journal Articles

Real-world outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia treated with IDH1 and IDH2 inhibitors in the frontline setting

Alifya Lokhandwala, Cilomar Martins de Oliveira Filho, Philip Amrein, Amir Fathi, Gabriela Hobbs, Hanno Hock, Rupa Narayan, Andrew Brunner, Michelle Lee

Blood (2025) 146 (Supplement 1): 8171.

https://doi.org/10.1182/blood-2025-8171

Published: 2025

Journal Articles

Patient and clinician perspectives on the diagnosis and management of polycythemia vera: Results from concurrent surveys

Makaela Premont, Aaron Gerds, Gabriela Hobbs, Sara Douglas, Christina Persaud, Jonathan Moss, Emir Hadzic

Blood (2025) 146 (Supplement 1): 2653.

https://doi.org/10.1182/blood-2025-2653

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Thrombosis, bleeding, and progression in JAK2 V617F clonal hematopoiesis

Real-world treatment patterns and clinical outcomes in patients with essential thrombocythemia treated with cytoreductive therapy: A retrospective analysis of electronic health records data

The association of a novel psychosocial and mobility assessment with outcomes of veterans with acute myeloid leukemia (AML)

A retrospective study to assess real-world treatment patterns and outcomes in luspatercept-treated patients with myelofibrosis-associated anemia who required red blood cell transfusion in the United States

Peripheral blood plasma proteomics reveals dysregulated cholesterol transport and complement pathways in myeloproliferative neoplasms

Decreased serum total cholesterol is associated with worse outcomes among patients with myeloproliferative neoplasms

Cytoreductive therapy reduces recurrent thrombosis in patients with myeloproliferative neoplasm-associated splanchnic vein thrombosis: A global abdominal/splanchnic thrombosis retrospective observational study (GASTRO-MPN) study of 757 patients

Clinical features and outcomes of myelofibrosis patients with MPL mutations

Clinical features and outcomes of myeloproliferative neoplasm patients with MPL mutations and concurrent JAK2/calr mutations

Pulmonary hypertension on right heart catheterization is associated with worse progression-free survival in patients with myeloproliferative neoplasms

Impact of statin use on cardiovascular and hematologic outcomes among patients with myeloproliferative neoplasms

Retrospective real-world analysis of ropeginterferon ALFA-2B use in patients with polycythemia vera and essential thrombocythemia: Practice patterns, tolerance, and outcomes

Evaluating real-world diagnostic and treatment patterns, risk of thromboembolic events, and mortality for polycythemia vera across an integrated academic-community cancer network

Examining diet quality and patient-reported outcomes in myeloproliferative neoplasms: Results from a cross-sectional observational study

A phase I study of the combination of ruxolitinib and the ERK1/2 inhibitor ulixertinib in previously treated myelofibrosis patients.

Not so exclusive: Co-mutations in JAK2, MPL and CALR define distinct hematologic and clonal signatures

Ruxolitinib and cardiovascular outcomes among patients with myelofibrosis

Results from paradigm - a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemotherapy for newly diagnosed fit adults with acute myeloid leukemia

Real-world outcomes of myelodysplastic syndrome and chronic myelomonocytic leukemia treated with IDH1 and IDH2 inhibitors in the frontline setting

Patient and clinician perspectives on the diagnosis and management of polycythemia vera: Results from concurrent surveys

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only